These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6951549)

  • 1. Tissue polypeptide antigen - a new tumour marker?
    Wagner W; Husemann B; Becker H; Groitl H; Koerfgen HP; Hammerschmidt M
    Aust N Z J Surg; 1982 Feb; 52(1):41-3. PubMed ID: 6951549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
    Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
    Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
    Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
    J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
    Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
    Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
    Bruhn HD; Broers H; Euler H; Everding A; Feller AC; Hedderich J; Jostarndt L; Jooss B; Zurborn KH; Löffler H
    Dtsch Med Wochenschr; 1986 Aug; 111(34):1267-72. PubMed ID: 3461933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary results of the clinical use of TPA (tissue polypeptide antigen)].
    Dalla Pria AF; Guolo P; Piaserico PL; Ricci G; Berlanda G; Gobbi V; Minello S
    Arch De Vecchi Anat Patol; 1983 Jul; 65(2-3):301-13. PubMed ID: 6680294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical utility of tumor markers in gastric and colon cancer].
    Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of tissue polypeptide antigen in colorectal cancer].
    Uehara Y; Kojima O; Majima T; Ikeda E; Nishioka B; Fujita Y; Majima S
    Nihon Shokakibyo Gakkai Zasshi; 1984 Aug; 81(8):1767-72. PubMed ID: 6513104
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of the carcinoembryonic antigen in the diagnosis of colorectal cancer].
    Simici P; Popa F; Păunescu V; Herşcovici H
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(1):57-64. PubMed ID: 3158035
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological significance of tumor marker].
    Ochi Y
    Rinsho Byori; 1985 Aug; 33(8):831-8. PubMed ID: 3908745
    [No Abstract]   [Full Text] [Related]  

  • 15. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms].
    Morelli M; Nardi M; Valle M; Balducci D; Serafini D; Bernardini P
    Minerva Med; 1985 Sep; 76(34-35):1529-31. PubMed ID: 2412188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of immunologic markers in the diagnosis and monitoring of large-intestinal neoplasms].
    Harłozińska-Szmyrka A
    Pol Arch Med Wewn; 1992; 88(2-3):181-9. PubMed ID: 1492024
    [No Abstract]   [Full Text] [Related]  

  • 19. CEA and tumor markers.
    Holyoke ED; Cooper EH
    Semin Oncol; 1976 Dec; 3(4):377-85. PubMed ID: 63149
    [No Abstract]   [Full Text] [Related]  

  • 20. [The value of tissue polypeptide antigen (TPA) levels in malignant digestive system pathology].
    de Clippele C; Pluygers E; Baldewyns P; Beauduin M; Therasse G; de Neve de Roden A; Hermans J; Majois F; Pourbaix A
    Acta Gastroenterol Belg; 1987; 50(1):52-62. PubMed ID: 3425169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.